Scarica l'app Stockscreener
0.9688
2.17%
-0.0215
Pre-mercato:
1.00
0.0312
+3.22%
Precedente Chiudi:
$0.9903
Aprire:
$0.9901
Volume 24 ore:
11,571
Relative Volume:
0.32
Capitalizzazione di mercato:
$4.75M
Reddito:
$36.31M
Utile/perdita netta:
$-5.98M
Rapporto P/E:
-0.6525
EPS:
-1.4848
Flusso di cassa netto:
$-6.17M
1 W Prestazione:
-6.85%
1M Prestazione:
-11.93%
6M Prestazione:
-46.18%
1 anno Prestazione:
-26.05%
Intervallo 1D:
$0.953
$1.017
Intervallo di 1 settimana:
$0.953
$1.08
Portata 52W:
$0.953
$2.43
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Nome
Sunshine Biopharma Inc
Settore
Telefono
954-330-0684
Indirizzo
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
0.9688 | 4.90M | 36.31M | -5.98M | -6.17M | -1.4848 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
121.11 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.77 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
578.54 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie
Director Natan David receives 100,000 SBFM shares in stock award - Stock Titan
Returns Recap: What is Sunshine Biopharma Incs valuation compared to sector2026 Big Picture & Low Risk Investment Opportunities - baoquankhu1.vn
US Market Recap: Is Sunshine Biopharma Incs ROE strong enough2026 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Smart Money: What is Sunshine Biopharma Incs valuation compared to sectorTrade Exit Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Sunshine Biopharma Posts Modest 2025 Revenue Growth and Tightens Costs to Pursue Profitability - TipRanks
Sunshine Biopharma (NASDAQ: SBFM) details 2025 results and cost cuts - Stock Titan
SBFM Reports Increased Revenue and Outlines Future Growth Plans - GuruFocus
Sunshine Biopharma (SBFM) Aims for Cost Reductions to Enhance Pr - GuruFocus
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year - ACCESS Newswire
Sunshine Biopharma launched nine new drugs as 2025 sales hit $36.3M - Stock Titan
Sunshine Biopharma Inc. 2025 Annual Report: Generic Drug Portfolio, Proprietary Oncology & Antiviral Developments, and Corporate Strategy - Minichart
Sunshine Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M - Stock Titan
Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS - TradingView — Track All Markets
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Reactions: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesQuarterly Performance Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Sunshine Biopharma Delays Annual SEC Filing - TipRanks
[NT 10-K] Sunshine Biopharma Inc. SEC Filing - Stock Titan
SBFM PE Ratio & Valuation, Is SBFM Overvalued - Intellectia AI
Aug Wrap: Does Sunshine Biopharma Inc Equity Warrant stock have upside surprise potential - baoquankhu1.vn
Bear Alert: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Volume Leaders & Safe Capital Investment Plans - baoquankhu1.vn
Smart Money: Is Sunshine Biopharma Inc Equity Warrant benefiting from interest rate changesTrend Reversal & Weekly Top Gainers Alerts - baoquankhu1.vn
Sunshine Biopharma Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Guidance Update: What is the cash position of Sunshine Biopharma Inc Equity Warrant2026 Retail & Low Risk Entry Point Tips - baoquankhu1.vn
Sunshine Biopharma, Inc.: Fundamental Analysis and Financial Ratings | | US8677811064 - marketscreener.com
Revenue per share of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
SBFM Forecast, Price Target & Analyst Ratings | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) - ChartMill
Sunshine Biopharma's March Milestone: A Strategic Financial Review () - aktiencheck.de
Returns Recap: What are the future prospects of Sunshine Biopharma Inc Equity Warrant2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Sunshine Biopharma Engages Aegis for Warrant Solicitation - TipRanks
Sunshine Biopharma engages Aegis for three-month warrant solicitation, 10% fee on proceeds - TradingView
Sunshine Biopharma (SBFM) taps Aegis to solicit exercises of outstanding warrants - Stock Titan
Risk Check: Will Sunshine Biopharma Inc outperform its industry peersTrade Analysis Summary & Community Verified Trade Signals - baoquankhu1.vn
Sunshine Biopharma (SBFM) Board May Effect Up-to 1-for-10 Reverse Split - Stock Titan
SBFM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Gainers: Is Sunshine Biopharma Incs ROE strong enoughJuly 2025 Retail & Weekly High Momentum Picks - baoquankhu1.vn
SBFM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Retail: Is Sunshine Biopharma Inc Equity Warrant affected by consumer sentimentWeekly Stock Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Fund Flows: What is the Moat Score of Sunshine Biopharma IncTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Market Review: What is Sunshine Biopharma Incs valuation compared to sector2025 Historical Comparison & Expert Verified Movement Alerts - baoquankhu1.vn
SBFMW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SBFM (Sunshine Biopharma) Total Inventories : $14.06 Mil (As of Sep. 2025) - GuruFocus
Sunshine Biopharma board authorized to consider reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma board authorized to consider reverse stock split - Investing.com
Sunshine Biopharma Shareholders Approve Potential Reverse Stock Split - TipRanks
Sunshine Biopharma (SBFM) majority holder clears path for up to 1-for-10 reverse split - Stock Titan
Weekly Earnings: Will Sunshine Biopharma Inc. outperform its industry peersDollar Strength & High Win Rate Trade Alerts - mfd.ru
MSN Money - MSN
Is Sunshine Biopharma Inc. Equity Warrant benefiting from innovation trends2025 Buyback Activity & Verified Chart Pattern Signals - mfd.ru
SBFM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is Sunshine Biopharma Inc. a defensive stockJuly 2025 Outlook & Breakout Confirmation Trade Signals - mfd.ru
Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.06%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):